These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15819472)

  • 1. Alterations in the expression of androgen receptor, wild type-epidermal growth factor receptor and a mutant epidermal growth factor receptor in human prostate cancer.
    Olapade-Olaopa EO; Moscatello DK; MacKay EH; Sandhu DP; Terry TR; Wong AJ; Habib FK
    Afr J Med Med Sci; 2004 Sep; 33(3):245-53. PubMed ID: 15819472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma.
    Olapade-Olaopa EO; MacKay EH; Taub NA; Sandhu DP; Terry TR; Habib FK
    Clin Cancer Res; 1999 Mar; 5(3):569-76. PubMed ID: 10100708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-talk between the androgen receptor and the epidermal growth factor receptor leads to p38MAPK-dependent activation of mTOR and cyclinD1 expression in prostate and lung cancer cells.
    Recchia AG; Musti AM; Lanzino M; Panno ML; Turano E; Zumpano R; Belfiore A; Andò S; Maggiolini M
    Int J Biochem Cell Biol; 2009 Mar; 41(3):603-14. PubMed ID: 18692155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgen receptor versus erbB-1 and erbB-2 expression in human prostate neoplasms.
    Brys M; Stawinska M; Foksinski M; Barecki A; Zydek C; Miekos E; Krajewska WM
    Oncol Rep; 2004 Jan; 11(1):219-24. PubMed ID: 14654929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of androgen receptor and growth factors in premalignant lesions of the prostate.
    Harper ME; Glynne-Jones E; Goddard L; Mathews P; Nicholson RI
    J Pathol; 1998 Oct; 186(2):169-77. PubMed ID: 9924433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of transforming growth factor-alpha, epidermal growth factor and the epidermal growth factor receptor in adenocarcinoma of the prostate and benign prostatic hyperplasia.
    Myers RB; Kudlow JE; Grizzle WE
    Mod Pathol; 1993 Nov; 6(6):733-7. PubMed ID: 7508115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action.
    Migliaccio A; Di Domenico M; Castoria G; Nanayakkara M; Lombardi M; de Falco A; Bilancio A; Varricchio L; Ciociola A; Auricchio F
    Cancer Res; 2005 Nov; 65(22):10585-93. PubMed ID: 16288052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Altered endocytosis of epidermal growth factor receptor in androgen receptor positive prostate cancer cell lines.
    Bonaccorsi L; Nosi D; Muratori M; Formigli L; Forti G; Baldi E
    J Mol Endocrinol; 2007 Feb; 38(1-2):51-66. PubMed ID: 17242169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical comparative analysis of transforming growth factor alpha, epidermal growth factor, and epidermal growth factor receptor in normal, hyperplastic and neoplastic human prostates.
    De Miguel P; Royuela ; Bethencourt R; Ruiz A; Fraile B; Paniagua R
    Cytokine; 1999 Sep; 11(9):722-7. PubMed ID: 10479409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic identification of 14-3-3 sigma as a common component of the androgen receptor and the epidermal growth factor receptor signaling pathways of the human prostate epithelial cell line M12.
    Huang D; Liu X; Plymate SR; Idowu M; Grimes M; Best AM; McKinney JL; Ware JL
    Oncogene; 2004 Sep; 23(41):6881-9. PubMed ID: 15300238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer.
    Olapade-Olaopa EO; Moscatello DK; MacKay EH; Horsburgh T; Sandhu DP; Terry TR; Wong AJ; Habib FK
    Br J Cancer; 2000 Jan; 82(1):186-94. PubMed ID: 10638988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Androgen receptor controls EGFR and ERBB2 gene expression at different levels in prostate cancer cell lines.
    Pignon JC; Koopmansch B; Nolens G; Delacroix L; Waltregny D; Winkler R
    Cancer Res; 2009 Apr; 69(7):2941-9. PubMed ID: 19318561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression analysis reveals generation of an autocrine loop by a mutant epidermal growth factor receptor in glioma cells.
    Ramnarain DB; Park S; Lee DY; Hatanpaa KJ; Scoggin SO; Otu H; Libermann TA; Raisanen JM; Ashfaq R; Wong ET; Wu J; Elliott R; Habib AA
    Cancer Res; 2006 Jan; 66(2):867-74. PubMed ID: 16424019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
    Mukherjee B; Mayer D
    Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms.
    Scher HI; Sarkis A; Reuter V; Cohen D; Netto G; Petrylak D; Lianes P; Fuks Z; Mendelsohn J; Cordon-Cardo C
    Clin Cancer Res; 1995 May; 1(5):545-50. PubMed ID: 9816014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-regulation of integrin alpha2 surface expression by mutant epidermal growth factor receptor (EGFRvIII) induces aberrant cell spreading and focal adhesion formation.
    Ning Y; Zeineldin R; Liu Y; Rosenberg M; Stack MS; Hudson LG
    Cancer Res; 2005 Oct; 65(20):9280-6. PubMed ID: 16230389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies.
    Mimeault M; Batra SK
    Carcinogenesis; 2006 Jan; 27(1):1-22. PubMed ID: 16195239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
    Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
    Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The androgen receptor and prostate cancer invasion.
    Bonaccorsi L; Muratori M; Marchiani S; Forti G; Baldi E
    Mol Cell Endocrinol; 2006 Feb; 246(1-2):157-62. PubMed ID: 16376012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor (ErbB1) expression in prostate cancer progression: correlation with androgen independence.
    Shah RB; Ghosh D; Elder JT
    Prostate; 2006 Sep; 66(13):1437-44. PubMed ID: 16741920
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.